Claims for Patent: 7,202,075

Summary for Patent: 7,202,075

Title:	Isolated protein having hydroxynitrile lyase activity
Abstract:	New genes containing a DNA sequence coding for hydroxynitrile lyase, which genes can be prepared via a primer combination based on the DNA sequence of the 5\'-region of the mdl genes from the Prunus serotina and from Prunus amygdalus and/or a primer 2 based on the 3\'-region of the DNA sequences of one of the hydroxynitrile lyase isoenzymes from Prunus serotina or from Prunus amygdalus, subsequent amplification with a DNA polymerase using a DNA from organisms, containing genes coding for hydroxynitrile lyase, as templates and cloning, and also recombinant proteins which can be prepared in suitable host cells by heterologous expression of the DNA sequence of said HNL genes, and proteins and fusion proteins derived therefrom and use of said proteins for preparing (R)- or (S)-cyanohydrins.
Inventor(s):	Schwab; Helmut (Graz, AT), Glieder; Anton (Gleisdorf, AT), Kratky; Christoph (Graz, AT), Dreveny; Ingrid (Graz, AT), Bona; Rodolfo (Graz, AT), Pochlauer; Peter (Linz, AT), Skranc; Wolfgang (Vienna, AT), Mayrhofer; Herbert (Engerwitzdorf, AT), Wirth; Irma (Enns, AT), Neuhofer; Rudolf (Engerwitzdorf, AT)
Assignee:	DSM Fine Chemicals Austria NFG GmbH & Co KG (Linz, AT)
Application Number:	10/940,954
Patent Claims:	1. An isolated protein having hydroxynitrile lyase activity selected from the group consisting of: (1) a protein having hydroxynitrile lyase activity comprising the amino acid sequence of SEQ ID NO: 20; (2) a protein having hydroxynitrile lyase activity encoded by a nucleotide sequence having the nucleic acid sequence of SEQ ID NO: 19; (3) a protein having hydroxynitrile lyase activity encoded by a nucleotide sequence having at least 85% identity with the nucleic acid sequence of SEQ ID NO: 19; (4) a protein having hydroxynitrile lyase activity encoded by a nucleotide sequence having the nucleic acid sequence from nucleotide 13 to nucleotide 2151 of SEQ ID NO: 19; and (5) a protein having hydroxynitrile lyase activity encoded by a nucleotide sequence having the nucleic acid sequence of SEQ ID NO: 19 without the intron regions of nucleotides 116 to nucleotide 257, nucleotide 918 to nucleotide 1120, or nucleotide 1962 to nucleotide 2077. 2. The isolated protein of claim 1, wherein the protein is recombinantly produced. 3. The recombinant protein of claim 2 which is obtained by heterologous expression. 4. The recombinant protein of claim 2, which comprises host-specific glycosylation. 5. The recombinant protein of claim 2, wherein the protein is prepared by expression in an eukaryotic microorganism. 6. The recombinant protein of claim 2, wherein said protein is prepared by expression in a fungus. 7. An isolated fusion protein or heterologous protein having hydroxynitrile lyase activity selected from the group consisting of: (1) a protein having hydroxynitrile lyase activity having the amino acid sequence of SEQ ID NO: 22; and (2) a protein having hydroxynitrile lyase activity encoded by a nucleotide sequence having the nucleic acid sequence of SEQ ID NO: 21 having the 5' and 3' terminal portions of the nucleotide sequence encoding Aspergillus niger glucose oxidase protein. 8. An isolated protein having hydroxynitrile lyase activity selected from the group consisting of: (1) a protein having the amino acid sequence of SEQ ID NO: 24; and (2) a protein encoded by a nucleotide sequence having the nucleic acid sequence of SEQ ID NO: 23. 9. A method for producing (R)- or (S)-cyanohydrins comprising contacting the protein having hydroxynitrile lyase activity of claim 1 with aliphatic, aromatic or heteroaromatic aldehydes and ketones in an organic, aqueous or 2-phase system or in emulsion in the presence of a cyanide group donor. 10. A method for producing (R)- or (S)-cyanohydrins comprising contacting the recombinant protein having hydroxynitrile lyase activity of claim 2 with aliphatic, aromatic or heteroaromatic aldehydes and ketones in an organic, aqueous or 2-phase system or in emulsion in the presence of a cyanide group donor. 11. A method for producing (R)- or (S)-cyanohydrins comprising contacting the fusion protein or heterologous protein having hydroxynitrile lyase activity of claim 7 with aliphatic, aromatic or heteroaromatic aldehydes and ketones in an organic, aqueous or 2-phase system or in emulsion in the presence of a cyanide group donor. 12. A method for producing (R)- or (S)-cyanohydrins comprising contacting the protein having hydroxynitrile lyase activity of claim 8 with aliphatic, aromatic or heteroaromatic aldehydes and ketones in an organic, aqueous or 2-phase system or in emulsion in the presence of a cyanide group donor.

Details for Patent 7,202,075

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2021-01-16
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2021-01-16
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2021-01-16